Baqsimi ® (glucagon) nasal powder

3mg

This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.

What is Baqsimi™ (glucagon) nasal powder indicated for?

Glucagon nasal powder is indicated for the treatment of severe hypoglycemia in patients with diabetes ages 4 and above.

US_cFAQ_NG035_INDICATION
US_cFAQ_NG035_INDICATION
en-US

Indication

Baqsimi is an antihypoglycemic agent indicated for the treatment of severe hypoglycemia in patients with diabetes ages 4 and above.1

Reference

1Baqsimi [package insert]. Indianapolis, IN: Eli Lilly and Company; 2020.

Date of Last Review: October 25, 2021


Contact Lilly

Call Us

If you need information about a Lilly product or want to report an Adverse Event or Product Complaint, you may call us.

Available Mon – Friday, 9am-7pm (EST), excluding holidays

Or you can

Chat with us

Chat with us

Submit a Request

Visit Us @LillyMedical